Easom Eric

Average Profitability
61.1%
Insider Buys Quantity
2
Insider Buys Sum
$103,740.00
Insider Sells Quantity
17
Insider Sells Sum
$1.55M

Insider Activity of Easom Eric

According to the SEC Form 4 filings, Easom Eric, being in a position of

  1. Chief Executive Officer at AN2 Therapeutics, Inc.,
    оver the last 12 months, has bought 50000 shares for $49,970, and sold 2777 shares for $55,802,
    over all time since 2022-10-20, has bought 60000 shares for $103,740, and sold 97008 shares for $1.55M.

The largest purchase of all time was on 2023-05-15 and amounted to 10000 shares of AN2 Therapeutics, Inc. for $53,770.

The largest sale of all time was on 2022-10-21 and amounted to 13951 share of AN2 Therapeutics, Inc. for $228,240.

Biography of Easom Eric

No biography is available at this moment.

2024-11-18PurchaseAN2 Therapeutics, Inc.
ANTX
Chief Executive Officer
50,000
0.1001%
$1.00$49,970+42%
2024-01-02SaleAN2 Therapeutics, Inc.
ANTX
Chief Executive Officer
2,777
0.1118%
$20.09$55,802-88.78%
2023-05-15PurchaseAN2 Therapeutics, Inc.
ANTX
Chief Executive Officer
10,000
0.1078%
$5.38$53,770+61.1%
2022-11-14SaleAN2 Therapeutics, Inc.
ANTX
Chief Executive Officer
23
0.0007%
$15.04$346-34.44%
2022-11-10SaleAN2 Therapeutics, Inc.
ANTX
Chief Executive Officer
4,413
0.1355%
$15.32$67,628-34.35%
2022-11-09SaleAN2 Therapeutics, Inc.
ANTX
Chief Executive Officer
10,111
0.3163%
$15.61$157,847-39.23%
2022-11-08SaleAN2 Therapeutics, Inc.
ANTX
Chief Executive Officer
7,055
0.2203%
$15.58$109,947-36.64%
2022-11-07SaleAN2 Therapeutics, Inc.
ANTX
Chief Executive Officer
12,203
0.3923%
$16.04$195,741-43.07%
2022-11-04SaleAN2 Therapeutics, Inc.
ANTX
Chief Executive Officer
8,828
0.2795%
$15.80$139,474-39.61%
2022-11-03SaleAN2 Therapeutics, Inc.
ANTX
Chief Executive Officer
14,165
0.447%
$15.75$223,058-39.46%
2022-11-02SaleAN2 Therapeutics, Inc.
ANTX
Chief Executive Officer
1,544
0.0466%
$15.07$23,263-35.58%
2022-10-31SaleAN2 Therapeutics, Inc.
ANTX
Chief Executive Officer
2,688
0.0829%
$15.39$41,363-33.08%
2022-10-28SaleAN2 Therapeutics, Inc.
ANTX
Chief Executive Officer
1,683
0.0509%
$15.09$25,392-35.96%
2022-10-27SaleAN2 Therapeutics, Inc.
ANTX
Chief Executive Officer
924
0.0284%
$15.36$14,190-37.38%
2022-10-26SaleAN2 Therapeutics, Inc.
ANTX
Chief Executive Officer
1,678
0.0508%
$15.10$25,342-35.41%
2022-10-25SaleAN2 Therapeutics, Inc.
ANTX
Chief Executive Officer
4,806
0.1517%
$15.75$75,672-38.57%
2022-10-24SaleAN2 Therapeutics, Inc.
ANTX
Chief Executive Officer
2,866
0.0929%
$16.17$46,344-40.91%
2022-10-21SaleAN2 Therapeutics, Inc.
ANTX
Chief Executive Officer
13,951
0.4574%
$16.36$228,240-41.22%
2022-10-20SaleAN2 Therapeutics, Inc.
ANTX
Chief Executive Officer
7,293
0.2438%
$16.68$121,672-41.94%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.